Functional Heterogeneity of Tamm-Horsfall Glycoprotein Isolated from Urines of Normal Subjects and Idiopathic Calcium-Oxalate Stone Formers and from Human Calcium-Oxalate Kidney Stones
Tamm-Horsfall glycoprotein (THP) has been described as a promoter or inhibitor of the aggregation of calcium oxalate monohydrate (COM) crystals (1). We have asked whether urinary THP from normal subjects (n THP) and idiopathic calcium oxalate stone formers (sf THP) and THP from human calcium oxalate stones (stone THP) differ in their ability to inhibit the aggregation of COM crystals in vitro, and - if such differences exist -what could be the mechanism of reduced crystal-aggregation inhibition.
KeywordsCalcium Oxalate Axial Ratio Calcium Oxalate Monohydrate Calcium Oxalate Stone Negative Zeta Potential
Unable to display preview. Download preview PDF.
- 3.Y Nakagawa, MA Ahmed, SL Hall, S Deganello, and FL Coe, Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth: evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in γcarboxyglutamic acid, J. Clin. Invest. 79: 1782 (1987).PubMedCrossRefGoogle Scholar
- 5.B Hess, Y Nakagawa, and FL Coe, New spectrophotometric method for measuring aggregation of calcium oxalate monohydrate crystals in the absence of supersaturation, in: this volume, p. 55.Google Scholar